Trials / Sponsors / Engrail Therapeutics INC
Engrail Therapeutics INC
Industry · 8 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of ENX-104 in Healthy Participants Healthy Volunteers | Phase 1 | 2026-02-25 |
| Completed | A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder Social Anxiety Disorder (SAD) | Phase 2 | 2025-09-05 |
| Recruiting | ENX-205 SAD/PET Study in Healthy Adults Healthy Volunteer | Phase 1 | 2025-03-23 |
| Completed | A PET Study of ENX-104 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2025-02-24 |
| Completed | ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD) Major Depressive Disorder | Phase 1 | 2025-02-17 |
| Completed | A Dose-Response Safety Study of ENX-102 in Patients With GAD General Anxiety Disorder | Phase 2 | 2024-12-09 |
| Completed | ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder | Phase 2 | 2023-07-03 |
| Withdrawn | ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures Focal Epilepsy | Phase 2 | 2022-09-01 |